Analysis of Brain Lipids in the Early-Onset Tay–sachs Disease Mouse Model With the Combined Deficiency of Β-Hexosaminidase a and Neuraminidase 3

dc.contributor.author Can, Melike
dc.contributor.author Şengül, Tuğçe
dc.contributor.author Akyıldız Demir, Seçil
dc.contributor.author İnci, Orhan K.
dc.contributor.author Basırlı, Hatice Hande
dc.contributor.author Seyrantepe, Volkan
dc.date.accessioned 2022-10-31T06:39:25Z
dc.date.available 2022-10-31T06:39:25Z
dc.date.issued 2022
dc.description.abstract Tay–Sachs disease is an autosomal recessively inherited lysosomal storage disease that results from loss-of-function mutations in the HEXA gene coding βhexosaminidase A. HEXA gene deficiency affects the central nervous system owing to GM2 ganglioside accumulation in lysosomes resulting in progressive neurodegeneration in patients. We recently generated a novel mice model with a combined deficiency of βhexosaminidase A and neuraminidase 3 (Hexa−/−Neu3−/−) that mimics both the neuropathological and clinical abnormalities of early-onset Tay–Sachs disease. Here, we aimed to explore the secondary accumulation of lipids in the brain of Hexa−/ −Neu3−/− mice. en_US
dc.identifier.doi 10.3389/fmolb.2022.892248
dc.identifier.issn 2296-889X en_US
dc.identifier.issn 2296-889X
dc.identifier.scopus 2-s2.0-85136490552
dc.identifier.uri https://doi.org/10.3389/fmolb.2022.892248
dc.identifier.uri https://hdl.handle.net/11147/12574
dc.language.iso en en_US
dc.publisher Frontiers Media S.A. en_US
dc.relation Erken Başlangıçlı Tay-Sachs Hastalığı Fare Modelinde Hücresel Patolojinin Araştırılması en_US
dc.relation.ispartof Frontiers in Molecular Biosciences en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Tay-Sachs disease en_US
dc.subject Mouse model en_US
dc.subject Lipidomics en_US
dc.subject Gangliosides en_US
dc.subject Brain en_US
dc.title Analysis of Brain Lipids in the Early-Onset Tay–sachs Disease Mouse Model With the Combined Deficiency of Β-Hexosaminidase a and Neuraminidase 3 en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id 0000-0002-0243-5011
gdc.author.id 0000-0002-0243-5011 en_US
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access open access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Institute of Technology. Molecular Biology and Genetics en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.volume 9 en_US
gdc.description.wosquality Q2
gdc.identifier.openalex W4290565567
gdc.identifier.pmid 36003081
gdc.identifier.wos WOS:000843171700001
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.accesstype GOLD
gdc.oaire.diamondjournal false
gdc.oaire.impulse 2.0
gdc.oaire.influence 2.6967044E-9
gdc.oaire.isgreen true
gdc.oaire.keywords QH301-705.5
gdc.oaire.keywords mouse model
gdc.oaire.keywords brain
gdc.oaire.keywords lipidomics
gdc.oaire.keywords Tay–Sachs disease
gdc.oaire.keywords Molecular Biosciences
gdc.oaire.keywords Biology (General)
gdc.oaire.keywords gangliosides
gdc.oaire.popularity 4.085943E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 0301 basic medicine
gdc.oaire.sciencefields 0303 health sciences
gdc.oaire.sciencefields 03 medical and health sciences
gdc.openalex.collaboration National
gdc.openalex.fwci 1.07697821
gdc.openalex.normalizedpercentile 0.69
gdc.opencitations.count 2
gdc.plumx.mendeley 17
gdc.plumx.pubmedcites 1
gdc.plumx.scopuscites 6
gdc.scopus.citedcount 6
gdc.wos.citedcount 6
relation.isAuthorOfPublication.latestForDiscovery cc5dbf8a-47c5-463f-8e8c-888beaf37b02
relation.isOrgUnitOfPublication.latestForDiscovery 9af2b05f-28ac-4013-8abe-a4dfe192da5e

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Name:
fmolb-09-892248.pdf
Size:
4.46 MB
Format:
Adobe Portable Document Format
Description:
Article (Makale)

License bundle

Now showing 1 - 1 of 1
Loading...
Name:
license.txt
Size:
3.2 KB
Format:
Item-specific license agreed upon to submission
Description: